StockWatch
·
Pharmaceuticals
Investment8 Aug 2026, 02:00 pm

Amwill Health Care Approves Hybrid Treasury Strategy

AI Summary

Amwill Health Care Ltd's Investment Committee has approved a hybrid treasury strategy to optimize surplus cash. The company will allocate funds across various investment avenues, including Government Securities (G-Secs), Treasury Bills, Government Bonds, Non-Convertible Debentures (NCDs), Commercial Papers, and Other Debt Securities up to ₹10 crore. Additionally, ₹2 crore is allocated for listed equity shares and IPO subscriptions, ₹15 crore for Private Credit Funds, Alternative Investment Funds (AIFs), Structured Debt Instruments, and other debt-oriented opportunities. Invoice discounting platforms and other investment opportunities will receive up to ₹3 crore, and Systematic Investment Plans (SIPs) in Mutual Funds will have a ceiling of ₹3 crore. This strategy aims to maintain liquidity and safety while seeking higher post-tax, risk-adjusted returns on excess capital. The investments do not involve any related party transactions.

Key Highlights

  • Amwill Health Care adopts a hybrid treasury strategy for surplus cash optimization.
  • Significant allocation towards debt instruments and G-Secs up to ₹10 crore.
  • Equity and IPO investments capped at ₹2 crore.
  • Alternative investments and private credit allocated up to ₹15 crore.
  • Focus on balancing safety with enhanced risk-adjusted returns.